| Intracellular Therapies Inc. (ITI) |
|
ITI
is a drug discovery company based in New York. ITI is developing novel
drugs for depression, schizophrenia, Parkinson's disease and other
CNS disorders. The company is focused on the signaling pathways that
occur inside nerve cells as elucidated by Dr. Paul Greengard, an ITI
cofounder, who won the Nobel Prize for Medicine in 2000.
|